BrainsWay Ltd. Company
Brainsway's patented breakthrough technology launches a new era in brain disorder treatment.
Total Funding:
65495696.0
Headquarters:
Jerusalem, Yerushalayim, Israel
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2021-02-23
Investors Number:
4.0
Founded Date:
2003-01-01
Industry:
Neurodegenerative disease diagnosis and treatment